PERCF (Percheron Therapeutics) Other Current Liabilities: $0.12 Mil (As of Dec. 2025)


What is Percheron Therapeutics Other Current Liabilities?

Percheron Therapeutics PERCF -0.18% Other Current Liabilities is $0.12 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Percheron Therapeutics's other current liabilities for the quarter that ended in Dec. 2025 was $0.12 Mil.

Percheron Therapeutics's quarterly other current liabilities declined from Dec. 2024 ($0.17 Mil) to Jun. 2025 ($0.11 Mil) but then increased from Jun. 2025 ($0.11 Mil) to Dec. 2025 ($0.12 Mil).

Percheron Therapeutics's annual other current liabilities increased from Jun. 2023 ($0.13 Mil) to Jun. 2024 ($0.16 Mil) but then declined from Jun. 2024 ($0.16 Mil) to Jun. 2025 ($0.11 Mil).

Percheron Therapeutics Other Current Liabilities Related Terms

Percheron Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Percheron Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Other Current Liabilities Chart

Percheron Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.37 0.13 0.16 0.11

Percheron Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.16 0.17 0.11 0.12

Percheron Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.12 Mil mean?
Percheron Therapeutics (PERCF) has a Other Current Liabilities of $0.12 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Percheron Therapeutics.
Is Percheron Therapeutics' Other Current Liabilities too high?
Percheron Therapeutics' current Other Current Liabilities is $0.12 Mil.
How does Percheron Therapeutics' Other Current Liabilities compare to ZTS and UTHR?
Percheron Therapeutics' Other Current Liabilities of $0.12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Percheron Therapeutics. Percheron Therapeutics's current Other Current Liabilities is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Percheron Therapeutics stock overvalued right now?
Percheron Therapeutics (PERCF) has a current Other Current Liabilities of $0.12 Mil. The current Other Current Liabilities is $0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Percheron Therapeutics (PERCF), the current Other Current Liabilities is $0.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Percheron Therapeutics Business Description

Other Exchanges AWY0:GermanyPER:Australia
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.